TY - JOUR
T1 - Pigment epithelial-derived factor in human fetal membranes
AU - Stalberg, Cecilia
AU - Noda, Nathalia
AU - Polettini, Jossimara
AU - Jacobson, Bo
AU - Menon, Ramkumar
N1 - Publisher Copyright:
© 2017 Informa UK Limited, trading as Taylor & Francis Group.
PY - 2018/8/3
Y1 - 2018/8/3
N2 - Objective: Our main objective was to document, pigment epithelial-derived factor (PEDF), a secreted serine protease inhibitor with anti-angiogenic, anti-inflammatory, and anti-oxidant properties, expression in human fetal membranes from preterm prelabor rupture of the membranes (pPROM) and in in vitro cultures stimulated with cigarette smoke extract (CSE) or lipopolysaccharides (LPS), two major risk factors for pPROM (behavioral and bacterial, respectively). Method: We documented PEDF mRNA expression in clinical samples of fetal membranes from patients with pPROM using quantitative RT-PCR. Also, mRNA and protein levels were documented in fetal membranes (from normal term cesarean sections [not in labor]) in an organ explant system stimulated with CSE or lipopolysaccharide (LPS). Immunohistochemistry (IHC) was used to localize PEDF in fetal membranes. Results: We report no changes in PEDF mRNA expression in pPROM compared to term births (p =.59) or after treatment with CSE or LPS. However, by adding sulforaphane the PEDF mRNA expression increased significantly p <.000032. PEDF was localized to both amnion and chorion layers, but no difference was seen in staining intensities after CSE or LPS treatment compared to control. Conclusions: PEDF, a product of fetal membrane cells, is unaltered in pPROM or after exposure to risk factors of pPROM. The antioxidant stimulating substance sulforaphane contribute to an increase in PEDF mRNA in fetal membranes.
AB - Objective: Our main objective was to document, pigment epithelial-derived factor (PEDF), a secreted serine protease inhibitor with anti-angiogenic, anti-inflammatory, and anti-oxidant properties, expression in human fetal membranes from preterm prelabor rupture of the membranes (pPROM) and in in vitro cultures stimulated with cigarette smoke extract (CSE) or lipopolysaccharides (LPS), two major risk factors for pPROM (behavioral and bacterial, respectively). Method: We documented PEDF mRNA expression in clinical samples of fetal membranes from patients with pPROM using quantitative RT-PCR. Also, mRNA and protein levels were documented in fetal membranes (from normal term cesarean sections [not in labor]) in an organ explant system stimulated with CSE or lipopolysaccharide (LPS). Immunohistochemistry (IHC) was used to localize PEDF in fetal membranes. Results: We report no changes in PEDF mRNA expression in pPROM compared to term births (p =.59) or after treatment with CSE or LPS. However, by adding sulforaphane the PEDF mRNA expression increased significantly p <.000032. PEDF was localized to both amnion and chorion layers, but no difference was seen in staining intensities after CSE or LPS treatment compared to control. Conclusions: PEDF, a product of fetal membrane cells, is unaltered in pPROM or after exposure to risk factors of pPROM. The antioxidant stimulating substance sulforaphane contribute to an increase in PEDF mRNA in fetal membranes.
KW - Serpinf1
KW - bacterial infection
KW - fetal membrane
KW - pPROM
KW - smoking
UR - http://www.scopus.com/inward/record.url?scp=85021152035&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85021152035&partnerID=8YFLogxK
U2 - 10.1080/14767058.2017.1335707
DO - 10.1080/14767058.2017.1335707
M3 - Article
C2 - 28562170
AN - SCOPUS:85021152035
SN - 1476-7058
VL - 31
SP - 2058
EP - 2065
JO - Journal of Maternal-Fetal and Neonatal Medicine
JF - Journal of Maternal-Fetal and Neonatal Medicine
IS - 15
ER -